Bynocs
PrivateMomentum
Top 50%
of companies Caplight tracks
Company Overview
Bynocs is a HealthTech company that provides an AI-powered, cloud-based digital vision therapy software to treat eye conditions like amblyopia (lazy eye), intermittent squint, and computer vision syndrome.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Telemedicine, Patient Engagement
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bynocs Comparables
Compare Bynocs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CureSee | 91% | |
| Vivid Vision | 88% | |
| AmblyoPlay | 84% | |
Bynocs Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 56% MoM.
- Mar 3, 2026
Monthly visitors increased 55% MoM, reaching 28.4K.
Bynocs Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bynocs's valuation, stock price, and market status.